SA Pharmaceutical Journal - Volume 81, Issue 4, 2014
Volume 81, Issue 4, 2014
"Vir sapit qui pauca loquitur" - Unknown
("That man is wise who talks little") : president's messageAuthor Johann KrugerSource: SA Pharmaceutical Journal 81 (2014)More Less
Author J. Van SchoorSource: SA Pharmaceutical Journal 81, pp 14 –18 (2014)More Less
The common cold is the most frequent human illness, and may be caused by several families of viruses, particularly the more than 100 serotypes of rhinoviruses. Inaccurate perceptions that antibiotics improve patient outcomes fuel the number of doctor visits and parental requests for antibiotics. The inappropriate use of antibiotics for minor, self-limiting, usually viral, upper-respiratory tract infections does not alter the course of the disease, and adds to the burden of antibiotic resistance. In addition, there is also no evidence to suggest that antibiotics prevent secondary bacterial complications following viral upper-respiratory tract infections. While most over-the-counter cold and flu remedies have no proven efficacy, they appear to attenuate the immune response to the infecting virus, and there is little doubt that appropriate symptomatic treatment can make the patient feel better. Therefore, symptomatic therapy remains the mainstay of common cold treatment. This article briefly reviews the components of cold and flu remedies, and provides a symptom-based assessment for the selection of appropriate over-the-counter medicine.
Author Lynn LambertSource: SA Pharmaceutical Journal 81, pp 20 –25 (2014)More Less
Patients often present at the pharmacy with complaints of "flu". Although flu is a common illness, the word "flu" is often used loosely to describe general feelings of ill health. However, in many instances, symptoms may be confused with those of an allergy. It is important to know and understand the difference between influenza and allergies such as hayfever, in order to ensure correct diagnosis and offer appropriate therapeutic approaches. This article will review the clinical manifestations of influenza and allergic rhinitis, and highlights the difference between these two illnesses.
Source: SA Pharmaceutical Journal 81, pp 28 –33 (2014)More Less
"Psychosis" is an umbrella term used in the description of various conditions that involve delusions and hallucinations. This article will focus on the management of schizophrenia. Schizophrenia is a complex disorder, which provides many pharmacotherapy-related challenges. Advances have been made in the treatment of the condition. However, this requires a team approach, with the pharmacist monitoring treatment, both for safety and efficacy. The involvement of medicines that might possibly modulate the N-methyl-D-aspartate receptors is an exciting development that should be monitored.
Author Gail MkeleSource: SA Pharmaceutical Journal 81, pp 34 –37 (2014)More Less
Medicine-induced sexual dysfunction is an adverse effect that is relatively common, and yet is poorly understood. Several classes of medicine cause or contribute to sexual dysfunction in both men and women. Sexual dysfunction attributed to the use of medicine can be a major cause of non-adherence to treatment. Healthcare professionals often find it difficult to discuss sexual function with their patients, and patients may also find this to be an awkward topic to raise. However, it is an important issue that needs to be understood and managed accordingly.
Author Jan Du ToitSource: SA Pharmaceutical Journal 81, pp 38 –40 (2014)More Less
Recent initiatives by the National Department of Health to provide an alternative chronic medicine access programme to public sector patients strengthened the belief that the preferred direction by government for improving accessibility to medicine for public sector patients was through centralised dispensing.
Source: SA Pharmaceutical Journal 81, pp 42 –48 (2014)More Less
The theme of this year's conference was "Taking stock", in recognition of the acknowledgement that the 20th anniversary of South Africa's democracy provides a wonderful opportunity to determine what has been achieved, so as to identify what still needs to be accomplished, and to re-energise our efforts to provide a quality pharmaceutical service in hospital and institutional settings.
Author Sandile MngadiSource: SA Pharmaceutical Journal 81, pp 49 –51 (2014)More Less
The pronouncement of the Regulations relating to the transparent pricing system for medicines and scheduled substances (Medicines and Related Substances Act 101 of 1965 as amended), introduced a Single Exit Price (SEP) for medicines in August 2004. The SEP is the price at which a manufacturer must sell to all pharmacies, irrespective of volume sold. The introduction of the single exit price ensured that no person shall supply any medicine according to a bonus system, rebate system or any other incentive scheme including sampling of medicines.
Author Stephan MollerSource: SA Pharmaceutical Journal 81 (2014)More Less
Have you ever spared a thought about the source of the catch phrase "thinking out of the box"? During the 1970s, Guilford studied creativity in people. Perhaps the most memorable of his studies was a puzzle that contained nine dots arranged in a perfect square. Participants were asked to connect all of the dots with straight lines, without lifting their pen. Fortunately today, many of us know about this particular puzzle and its solution, only because of its innate ability to illustrate the thinking-out-of-the-box concept.
Source: SA Pharmaceutical Journal 81, pp 54 –56 (2014)More Less
This month, we continue to look at ways in which the various schools of pharmacy are implementing the new curriculum. Prof Rod Walker from Rhodes University, Prof Shirley-Anne Boschmans from Nelson Mandela Metropolitan University (NMMU), and Prof Sandra van Dyk of North-West University (Potchefstroom Campus) describe how curricula changes have been effected at their respective universities.